Infarmed Denies Access to Innovative Breast Cancer Treatment

Source: Observador

Infarmed has rejected access to a promising breast cancer treatment for 12 women in Portugal, citing risk-benefit concerns. This innovative drug could significantly extend survival rates for patients with aggressive cancer types.

Health Legal & Justice